Intragenic PAX5 amplification defines a novel, relapse-prone subtype of B-cell precursor acute lymphoblastic leukemia with a poor outcome

Schwab, C., Nebral, K., Chilton, L., Leschi, C., Waanders, E., Boer, J., et al. (2017). Intragenic amplification of PAX5: A novel subgroup in B-cell precursor acute lymphoblastic leukemia?. BLOOD ADVANCES, 1(19), 1473-1477 [10.1182/bloodadvances.2017006734].

Intragenic amplification of PAX5: A novel subgroup in B-cell precursor acute lymphoblastic leukemia?

Fazio, Grazia;Cazzaniga, Giovanni;
2017

Abstract

Intragenic PAX5 amplification defines a novel, relapse-prone subtype of B-cell precursor acute lymphoblastic leukemia with a poor outcome
Articolo in rivista - Articolo scientifico
PAX5, B-cell precursor acute lymphoblastic leukemia, poor outcome
English
14-ago-2017
2017
1
19
1473
1477
open
Schwab, C., Nebral, K., Chilton, L., Leschi, C., Waanders, E., Boer, J., et al. (2017). Intragenic amplification of PAX5: A novel subgroup in B-cell precursor acute lymphoblastic leukemia?. BLOOD ADVANCES, 1(19), 1473-1477 [10.1182/bloodadvances.2017006734].
File in questo prodotto:
File Dimensione Formato  
Schwab_Intragenic PAXamp.pdf

accesso aperto

Tipologia di allegato: Author’s Accepted Manuscript, AAM (Post-print)
Dimensione 1.03 MB
Formato Adobe PDF
1.03 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/226314
Citazioni
  • Scopus 24
  • ???jsp.display-item.citation.isi??? 20
Social impact